English
简体中文
Total: £ 56.28
Published Date: 2025-04-23 | Pages: 93 | Tables: 95 | Pharma & Healthcare
The global Intravenous Immunoglobulin (IVIg) market size was US$ 11550 million in 2024 and is forecast to a readjusted size of US$ 17160 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
The global Intravenous Immunoglobulin (IVIg) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
By Type: (Dominant Segment vs High-Margin Innovation)
IVIg Liquid
IVIg Powder
By Application: (Core Demand Driver vs Emerging Opportunity)
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Baxter in Europe)
- Emerging Product Trends: IVIg Liquid adoption vs. IVIg Powder premiumization
- Demand-Side Dynamics: Immunodeficiency growth in China vs. Autoimmune Disease potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Intravenous Immunoglobulin (IVIg) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., IVIg Powder in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Autoimmune Disease in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., IVIg Liquid dominance in Europe vs. IVIg Powder demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Product Scope
1.2 Intravenous Immunoglobulin (IVIg) by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2020 & 2024 & 2031)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Intravenous Immunoglobulin (IVIg) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Intravenous Immunoglobulin (IVIg) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2025)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2020-2025)
2.3 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Intravenous Immunoglobulin (IVIg) Market Size and Prospective (2020-2031)
2.4.2 Europe Intravenous Immunoglobulin (IVIg) Market Size and Prospective (2020-2031)
2.4.3 China Intravenous Immunoglobulin (IVIg) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Type (2020-2025)
3.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2025)
3.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2020-2025)
3.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2020-2025)
3.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2026-2031)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2026-2031)
3.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2026-2031)
3.3 Different Types Intravenous Immunoglobulin (IVIg) Representative Players
4 Global Market Size by Application
4.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Review by Application (2020-2025)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2025)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2020-2025)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2020-2025)
4.2 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2026-2031)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2026-2031)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Intravenous Immunoglobulin (IVIg) Application
5 Competition Landscape by Players
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Players (2020-2025)
5.2 Global Top Intravenous Immunoglobulin (IVIg) Players by Revenue (2020-2025)
5.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2024)
5.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
5.7 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Company
6.1.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Company (2020-2025)
6.1.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025)
6.1.2 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2020-2025)
6.1.3 North America Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2020-2025)
6.1.4 North America Intravenous Immunoglobulin (IVIg) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company
6.2.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company (2020-2025)
6.2.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025)
6.2.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Intravenous Immunoglobulin (IVIg) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Intravenous Immunoglobulin (IVIg) Sales by Company
6.3.1.1 China Intravenous Immunoglobulin (IVIg) Sales by Company (2020-2025)
6.3.1.2 China Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025)
6.3.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2020-2025)
6.3.3 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2020-2025)
6.3.4 China Intravenous Immunoglobulin (IVIg) Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Baxter
7.1.1 Baxter Company Information
7.1.2 Baxter Business Overview
7.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
7.1.5 Baxter Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Business Overview
7.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
7.2.5 Grifols Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Business Overview
7.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
7.3.5 CSL Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
7.4.5 Octapharma Recent Development
7.5 Biotest
7.5.1 Biotest Company Information
7.5.2 Biotest Business Overview
7.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
7.5.5 Biotest Recent Development
7.6 Kedrion
7.6.1 Kedrion Company Information
7.6.2 Kedrion Business Overview
7.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
7.6.5 Kedrion Recent Development
7.7 Hualan Bio
7.7.1 Hualan Bio Company Information
7.7.2 Hualan Bio Business Overview
7.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
7.7.5 Hualan Bio Recent Development
7.8 CNBG
7.8.1 CNBG Company Information
7.8.2 CNBG Business Overview
7.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
7.8.5 CNBG Recent Development
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Company Information
7.9.2 Shanghai RAAS Business Overview
7.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
7.9.5 Shanghai RAAS Recent Development
7.10 CBPO
7.10.1 CBPO Company Information
7.10.2 CBPO Business Overview
7.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
7.10.5 CBPO Recent Development
7.11 LFB Group
7.11.1 LFB Group Company Information
7.11.2 LFB Group Business Overview
7.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
7.11.5 LFB Group Recent Development
7.12 BPL
7.12.1 BPL Company Information
7.12.2 BPL Business Overview
7.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 BPL Intravenous Immunoglobulin (IVIg) Products Offered
7.12.5 BPL Recent Development
7.13 Sichuan Yuanda Shuyang
7.13.1 Sichuan Yuanda Shuyang Company Information
7.13.2 Sichuan Yuanda Shuyang Business Overview
7.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
7.13.5 Sichuan Yuanda Shuyang Recent Development
8 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
8.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
8.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Intravenous Immunoglobulin (IVIg) Distributors List
9.3 Intravenous Immunoglobulin (IVIg) Customers
10 Intravenous Immunoglobulin (IVIg) Market Dynamics
10.1 Intravenous Immunoglobulin (IVIg) Industry Trends
10.2 Intravenous Immunoglobulin (IVIg) Market Drivers
10.3 Intravenous Immunoglobulin (IVIg) Market Challenges
10.4 Intravenous Immunoglobulin (IVIg) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Intravenous Immunoglobulin (IVIg) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Intravenous Immunoglobulin (IVIg) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Region (2020-2025)
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2025)
Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Region (2020-2025)
Table 8. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Region (2026-2031)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Share Forecast by Region (2026-2031)
Table 12. Global Intravenous Immunoglobulin (IVIg) Sales by Type (K Bottle) & (2020-2025)
Table 13. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2020-2025)
Table 14. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Intravenous Immunoglobulin (IVIg) Price by Type (USD/Bottle) & (2020-2025)
Table 16. Global Intravenous Immunoglobulin (IVIg) Sales by Type (K Bottle) & (2026-2031)
Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Intravenous Immunoglobulin (IVIg) Price by Type (USD/Bottle) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Intravenous Immunoglobulin (IVIg) Sales by Application (K Bottle) & (2020-2025)
Table 21. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2020-2025)
Table 22. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Intravenous Immunoglobulin (IVIg) Price by Application (USD/Bottle) & (2020-2025)
Table 24. Global Intravenous Immunoglobulin (IVIg) Sales by Application (K Bottle) & (2026-2031)
Table 25. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Intravenous Immunoglobulin (IVIg) Price by Application (USD/Bottle) & (2026-2031)
Table 27. New Sources of Growth in Intravenous Immunoglobulin (IVIg) Application
Table 28. Global Intravenous Immunoglobulin (IVIg) Sales by Company (K Bottle) & (2020-2025)
Table 29. Global Intravenous Immunoglobulin (IVIg) Sales Share by Company (2020-2025)
Table 30. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Company (2020-2025)
Table 32. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2024)
Table 33. Global Market Intravenous Immunoglobulin (IVIg) Average Price by Company (USD/Bottle) & (2020-2025)
Table 34. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
Table 36. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Intravenous Immunoglobulin (IVIg) Sales by Company (2020-2025) & (K Bottle)
Table 39. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2020-2025)
Table 40. North America Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2020-2025)
Table 42. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2025) & (K Bottle)
Table 43. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2025)
Table 44. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2025) & (K Bottle)
Table 45. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2025)
Table 46. Europe Intravenous Immunoglobulin (IVIg) Sales by Company (2020-2025) & (K Bottle)
Table 47. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2020-2025)
Table 48. Europe Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2020-2025)
Table 50. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2025) & (K Bottle)
Table 51. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2025)
Table 52. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2025) & (K Bottle)
Table 53. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2025)
Table 54. China Intravenous Immunoglobulin (IVIg) Sales by Company (2020-2025) & (K Bottle)
Table 55. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Company (2020-2025)
Table 56. China Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2020-2025)
Table 58. China Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2025) & (K Bottle)
Table 59. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2025)
Table 60. China Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2025) & (K Bottle)
Table 61. China Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2025)
Table 62. Baxter Company Information
Table 63. Baxter Description and Business Overview
Table 64. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 65. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 66. Baxter Recent Development
Table 67. Grifols Company Information
Table 68. Grifols Description and Business Overview
Table 69. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 70. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 71. Grifols Recent Development
Table 72. CSL Company Information
Table 73. CSL Description and Business Overview
Table 74. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 75. CSL Intravenous Immunoglobulin (IVIg) Product
Table 76. CSL Recent Development
Table 77. Octapharma Company Information
Table 78. Octapharma Description and Business Overview
Table 79. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 80. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 81. Octapharma Recent Development
Table 82. Biotest Company Information
Table 83. Biotest Description and Business Overview
Table 84. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 85. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 86. Biotest Recent Development
Table 87. Kedrion Company Information
Table 88. Kedrion Description and Business Overview
Table 89. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 90. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 91. Kedrion Recent Development
Table 92. Hualan Bio Company Information
Table 93. Hualan Bio Description and Business Overview
Table 94. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 95. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 96. Hualan Bio Recent Development
Table 97. CNBG Company Information
Table 98. CNBG Description and Business Overview
Table 99. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 100. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 101. CNBG Recent Development
Table 102. Shanghai RAAS Company Information
Table 103. Shanghai RAAS Description and Business Overview
Table 104. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 105. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 106. Shanghai RAAS Recent Development
Table 107. CBPO Company Information
Table 108. CBPO Description and Business Overview
Table 109. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 110. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 111. CBPO Recent Development
Table 112. LFB Group Company Information
Table 113. LFB Group Description and Business Overview
Table 114. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 115. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 116. LFB Group Recent Development
Table 117. BPL Company Information
Table 118. BPL Description and Business Overview
Table 119. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 120. BPL Intravenous Immunoglobulin (IVIg) Product
Table 121. BPL Recent Development
Table 122. Sichuan Yuanda Shuyang Company Information
Table 123. Sichuan Yuanda Shuyang Description and Business Overview
Table 124. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 125. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 126. Sichuan Yuanda Shuyang Recent Development
Table 127. Production Base and Market Concentration Rate of Raw Material
Table 128. Key Suppliers of Raw Materials
Table 129. Intravenous Immunoglobulin (IVIg) Distributors List
Table 130. Intravenous Immunoglobulin (IVIg) Customers List
Table 131. Intravenous Immunoglobulin (IVIg) Market Trends
Table 132. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 133. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 134. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type in 2024 & 2031
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Intravenous Immunoglobulin (IVIg) Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2024 & 2031
Figure 8. Immunodeficiency Examples
Figure 9. Autoimmune Disease Examples
Figure 10. Acute Infection Examples
Figure 11. Global Intravenous Immunoglobulin (IVIg) Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2020-2031)
Figure 14. Global Intravenous Immunoglobulin (IVIg) Price Trends Growth Rate (2020-2031) & (USD/Bottle)
Figure 15. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 16. Global Market Intravenous Immunoglobulin (IVIg) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2020-2031)
Figure 20. Europe Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2020-2031)
Figure 22. China Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate (2020-2031)
Figure 24. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2020-2025)
Figure 25. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2026-2031)
Figure 26. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2026-2031)
Figure 27. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2020-2025)
Figure 28. Global Intravenous Immunoglobulin (IVIg) Revenue Growth Rate by Application in 2020 & 2024
Figure 29. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2026-2031)
Figure 30. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2026-2031)
Figure 31. Global Intravenous Immunoglobulin (IVIg) Sales Share by Company (2024)
Figure 32. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Company (2024)
Figure 33. Global 5 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue in Intravenous Immunoglobulin (IVIg): 2020 & 2024
Figure 34. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 35. Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure 36. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 37. Intravenous Immunoglobulin (IVIg) Industrial Chain
Figure 38. Channels of Distribution (Direct Vs Distribution)
Figure 39. Distributors Profiles
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
